Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 19, 2003

Study Completion Date

December 10, 2007

Conditions

Thrombosis

Interventions

PROCEDURE

Pulse-sprayed injection of recombinant tissue plasminogen activator (rtPA)

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00055159 - Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins | Biotech Hunter | Biotech Hunter